SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Revenue recognition (Details)	3 Months Ended		9 Months Ended
	Sep. 30, 2022 USD ($)	Sep. 30, 2021 USD ($)	Sep. 30, 2022 USD ($) item	Sep. 30, 2021 USD ($)	Dec. 31, 2021 USD ($)
Revenue recognition
Estimated contractual allowance	$ 2,700,000		$ 2,700,000		$ 6,200,000
Period for return of incorrect domestic shipments			10 days
Number of times overstocking returns are limited | item			2
Period for return of product due to overstock			12 months
Maximum percentage of distributor's total purchase for the prior 12-month period			1.00%
License revenue payable to patent owner, as a percent			50.00%
Revenue recognized from contracts with customers and licensing fees recognized	23,061,285	$ 36,356,047	$ 82,140,204	$ 128,926,716
U.S. | U.S. sales (excluding U.S. government)
Revenue recognition
Revenue recognized from contracts with customers and licensing fees recognized	9,197,133	15,653,047	28,971,783	39,336,134
U.S. | Sales to U.S. government
Revenue recognition
Revenue recognized from contracts with customers and licensing fees recognized		18,420,480	15,731,136	83,560,680
North and South America (excluding U.S.) | North and South America sales (excluding U.S.)
Revenue recognition
Revenue recognized from contracts with customers and licensing fees recognized	9,841,536	701,802	24,657,232	3,161,418
Other international | Other international sales
Revenue recognition
Revenue recognized from contracts with customers and licensing fees recognized	4,022,616	1,580,718	12,780,053	2,868,484
Syringes
Revenue recognition
Revenue recognized from contracts with customers and licensing fees recognized	20,688,078	31,513,599	74,791,929	119,371,010
Syringes | U.S. | U.S. sales (excluding U.S. government)
Revenue recognition
Revenue recognized from contracts with customers and licensing fees recognized	6,947,856	11,033,291	22,220,324	30,685,338
Syringes | U.S. | Sales to U.S. government
Revenue recognition
Revenue recognized from contracts with customers and licensing fees recognized		18,420,480	15,731,136	83,560,680
Syringes | North and South America (excluding U.S.) | North and South America sales (excluding U.S.)
Revenue recognition
Revenue recognized from contracts with customers and licensing fees recognized	9,825,120	670,602	24,421,790	2,963,930
Syringes | Other international | Other international sales
Revenue recognition
Revenue recognized from contracts with customers and licensing fees recognized	3,915,102	1,389,226	12,418,679	2,161,062
Blood Collection Products
Revenue recognition
Revenue recognized from contracts with customers and licensing fees recognized	824,554	565,765	2,675,119	1,659,231
Blood Collection Products | U.S. | U.S. sales (excluding U.S. government)
Revenue recognition
Revenue recognized from contracts with customers and licensing fees recognized	815,964	560,065	2,419,915	1,590,891
Blood Collection Products | North and South America (excluding U.S.) | North and South America sales (excluding U.S.)
Revenue recognition
Revenue recognized from contracts with customers and licensing fees recognized		4,800		4,800
Blood Collection Products | Other international | Other international sales
Revenue recognition
Revenue recognized from contracts with customers and licensing fees recognized	8,590	900	255,204	63,540
EasyPoint Needles
Revenue recognition
Revenue recognized from contracts with customers and licensing fees recognized	1,523,784	4,264,684	4,400,631	7,743,240
EasyPoint Needles | U.S. | U.S. sales (excluding U.S. government)
Revenue recognition
Revenue recognized from contracts with customers and licensing fees recognized	1,426,060	4,048,292	4,294,603	7,019,560
EasyPoint Needles | North and South America (excluding U.S.) | North and South America sales (excluding U.S.)
Revenue recognition
Revenue recognized from contracts with customers and licensing fees recognized		26,400	2,608	83,248
EasyPoint Needles | Other international | Other international sales
Revenue recognition
Revenue recognized from contracts with customers and licensing fees recognized	97,724	189,992	103,420	640,432
Other Products
Revenue recognition
Revenue recognized from contracts with customers and licensing fees recognized	24,869	11,999	272,525	153,235
Other Products | U.S. | U.S. sales (excluding U.S. government)
Revenue recognition
Revenue recognized from contracts with customers and licensing fees recognized	7,253	11,399	36,941	40,345
Other Products | North and South America (excluding U.S.) | North and South America sales (excluding U.S.)
Revenue recognition
Revenue recognized from contracts with customers and licensing fees recognized	16,416		232,834	109,440
Other Products | Other international | Other international sales
Revenue recognition
Revenue recognized from contracts with customers and licensing fees recognized	$ 1,200	$ 600	$ 2,750	$ 3,450